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Abstract
Background: The monocarboxylate transporter 8 (MCT8) is a member of the major facilitator superfamily (MFS)
and transports specificly iodothyronines. MCT8 mutations are the underlying cause of a syndrome of severe X-
linked psychomotor retardation known as the Allan-Herndon-Dudley syndrome. This syndrome is characterized by
abnormally high T3, low/normal T4 serum levels and slightly elevated serum TSH. To date, more than 25
pathogenic mutations in hMCT8 are known and they are valuable indicators of important regions for structural and
functional MCT8 properties.
Methods: We designed a structural human MCT8 model and studied reported pathogenic missense mutations
with focus on the estimation of those amino acid positions which are probably sensitive for substrate transport.
Furthermore, assuming similarities between determinants of T3 binding observed in the published crystal structure
of the thyroid hormone receptor beta occupied by its ligand T3 and the structural MCT8 model, we explore
potential T3 binding sites in the MCT8 substrate channel cavity.
Results: We found that all known pathogenic missense mutations are located exclusively in the transmembrane
helices and to a high degree at conserved residues among the MCT family. Furthermore, mutations either of or to
prolines/glycines are located mainly at helices 9-12 and are expected to cause steric clashes or structural
misfolding. In contrast, several other mutations are close to the potential substrate channel and affected amino
acids are likely involved in the switching mechanism between different transporter conformations. Finally, three
potential substrate binding sites are predicted for MCT8.
Conclusions: Naturally occurring mutations of MCT8 provide molecular insights into protein regions important for
protein folding, substrate binding and the switching mechanism during substrate transport. Future studies guided
by this information should help to clarify structure-function relationships at MCT8 which may bear broader
relevance for other members of the MCT family. This includes decoding of the complete set of transport-sensitive
residue positions and description of structural re-arrangements during transport.
Introduction
The Allan-Herndon-Dudley syndrome is an X-linked
mental retardation first described in 1944 [1]. Neonates
are lacking head-moving control and they are character-
ized by feeding problems. Severe psychomotor retarda-
tion becomes more obvious with increasing age and
some patients never attain speech or the ability to walk.
An abnormal thyroid hormone constellation was found
as a characteristic signature for this syndrome and
guided the identification of mutations in MCT8 in
affected patients [2,3]. This constellation is a combina-
tion of high T3 levels with low/normal T4 and slightly
increased TSH in human serum. To date, more than 25
pathogenic mutations have been identified including
missense, nonsense, deletions, insertions, and splice site
mutations [4].
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MCT8 is a member of the major facilitator superfam-
ily (MFS) of membrane transporters and is structurally
characterized by twelve transmembrane helices con-
nected by intra- and extracellular loops. The N- and
C-termini are both located intracellularly [5]. MCT8
was described as a specific iodothyronine transporter [6]
and known substrates for human MCT8 are thyroxine
(3,3’,5,5’-tetraiodo-L-thyronine, T4), T3 (3,3’,5-triiodo-L-
thyronine), rT3 (3,3`,5’-triiodo-L-thyronine), and 3,3’-T2
(3,3’-diiodo-L-thyronine) [6,7].
It is assumed that substrate binding by MFS transpor-
ters triggers the transition between an “outside-open”
and “inside-open” conformation, the so-called “rocker-
switch” model [8,9]. This structural movement must be
linked with specific intramolecular events like re-
arrangement of amino acid interactions and also with
substrate trans-localization. Despite the need of more
supporting and detailed information for this structural-
functional “rocker-switch” model, specific substrate-pro-
tein interactions need to be considered as to be causally
related to different protein conformations. Of note, this
model should be also applicable for the reverse way of
substrate transport (i.e. efflux cycle) from the cytosolic
to the extracellular site. So far, details and principles of
the process are only partially known.
Naturally occurring missense mutations point to func-
tionally and structurally important residues within the
MCT8 protein. Mutations may affect protein folding
and stability or directly modify the mechanism of
iodothyronine transport [10]. We here explored the spa-
tial localization, molecular environment and the poten-
tial function of their wild-type amino acids at a three-
dimensional “inside-open” MCT8 model, the only struc-
tural conformation where templates for homology mod-
els are available. We will also discuss the results of
previous studies to evaluate the MCT8 homology model
and to extent generally our knowledge regarding mole-
cular mechanisms at MCTs.
Material and methods
Homology modelling of MCT8
The crystal structure of the Glycerol-3-phosphate trans-
porter (GlpT) in an “inside-open” conformation was
used as a structural template for the human MCT8
(hMCT8) homology model (PDB code 1PW4 [8]).
Despite low sequence identity between this template
and other members of MFS like MCT8, models based
on this structural template are supported by experimen-
tal data concerning GLUT1 [11], MCT1 [12,13], and
OATP1C1 [14]. The potential dimensions of MCT8
transmembrane helices (TMHs) were defined based on
helices in the template crystal structure. For consistency
we confirmed these dimensions with other available
MFS crystal structures (PDB codes 1PV6 and 1PV7
[15]). For further structural information of MCTs see
also the internet platform “Membrane transporter sys-
tems” at http://www.membranetransport.org.
Gaps of missing residues in loop regions of the tem-
plate structure were closed either manually or by the
‘Loop Search’ tool implemented in Sybyl 7.35 (Tripos
Inc., St. Louis, MO, USA). Side chains and loops of the
homology model were subjected to conjugate gradient
minimization (until converging at a termination gradient
of 0.05 kcal/(mol*Å)). The side chain orientations were
refined during dynamic simulation (8 ns) by fixing all
backbone H-bonds of TMHs. This step of model gen-
eration is extended compared to the recently published
MCT8 model [7] (5 ns) to get more precise potential
MCT8 side chain orientations. Finally, the model was
minimized without any constraints.
We have mapped naturally occurring single side chain
substitutions (figure 1) on our MCT8 model (figures 2
and 3). Pathogenic deletions or insertions (reviewed in
[4]) are not considered here, since they lead to incom-
plete proteins or they modify the particular helix-con-
formation and arrangements relative to each other.
Therefore, such mutations are revoking a consistent
structural prediction.
Structure images were produced using the PyMOL
Molecular Graphics System, Version 1.3, Schrödinger,
LLC.
Amino acid sequence alignment of human MCTs and the
unification of residue numbering
Amino acid sequences of human MCT family members
were aligned to analyze shared and divergent features in
amino acid composition (figure 4). Details of the align-
ment procedure are recently described by Kinne and
Kleinau et al. [7]. The alignment was used to highlight
positions of pathogenic MCT8 mutations. This align-
ment enables comparison and analyses of residue con-
servation among human MCTs (figure 1).
We suggested previously a unifying numbering system
for MCTs similar to family A GPCRs [7]. This position
identifier scheme uses a highly conserved residue in
each TMH as a common reference for all members of
the MCT family. The first number is related to the par-
ticular helix, the second number after the dot deter-
mines the specific position in relation to the conserved
residue. For example, the highly conserved tryptophan
in TMH1 is defined as 1.50 and the highly conserved
proline from TMH2 is defined as 2.50 (figure 4).
Results and discussion
The structural MCT8 model: molecular insights and
predictivity
Structural models represent potential conformations of
the target macro-molecule. Because of the well known
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causal dependency between specific biological functions
(like substrate binding or transport mechanisms at
MCTs) and particular structural features, structural
models are useful to guide experimental approaches or
to support the interpretation of experimental data. In
our recent study, we identified two functionally impor-
tant amino acids located at TMH8 and TMH10 [7]. In
this study we started with the hypothesis that two speci-
fic charged amino acids in the transmembrane region
(R4458.50 and D49810.49) may interact with the amino
acid backbone of iodothyronines. To prove this hypoth-
esis, we have mutated both residues to alanine and
tested transport of the natural substrate T3, as well as
of two substrates lacking either the carboxyl or the
Figure 1 Naturally occurring missense substitutions in human MCT8. In this table naturally occurring pathogenic amino acid substitutions
known for MCT8 are summarized. Specific background-colours indicate structural/functional and biophysical specificities: violet – mutations at or
to proline/glycines, respectively; red – side chain substitutions in the vicinity of the presumed substrate channel (figures 2 and 3); green – amino
acids pointing towards the membrane. We also provide a summary on conservation of respective amino acids within the MCT family based on
the alignment in figure 4 (bold are positions where more than half of the MCTs have an identical amino acid). The unified position numbering
suggested in a recent study [7] is provided (for description see section Material and Methods).
Figure 2 Homology model of human MCT8 with highlighted naturally occurring side chain substitutions. A) We highlighted wild-type
amino acids of known naturally occurring mutations on the homology model of monocarboxylate transporter 8 in a conformation open to the
cytosol (see figure 1). Colours were assigned according to the colour scheme in figure 1. From this three-dimensional mapping it becomes clear
that none of these mutations are localized in the extra- or intracellular loops. B) The clipped surface-presentation of the MCT8 protein reveals
the presumed substrate channel from the intracellular side.
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amino group, 3,3’,5-triiodo-thyronamine and 3,3’,5-
triiodo-thyroacetic acid. Both alanine mutants were
inactive towards all three substrates. These findings sup-
port our assumption that both amino acids are impor-
tant for substrate transport. The MCT8 model also
predicted a potential salt bridge between both amino
acids and an H-bond from R445 to the helix-backbone
adjusting the relative orientation between TMH8 and
TMH10. In conclusion, these two residues may have a
dual function for substrate interaction and for the con-
formational switch mechanism. Interestingly, positively
charged residues corresponding to MCT8 position
4458.50 can be found in all MCTs. This position and
spatial region may bear a fundamental role, since also in
other twelve helix-transporters positively charged resi-
dues are suggested or evidenced to participate in the
transport mechanisms, e.g. for GlpT [8], MCT1 [13],
and OATP1C1 [14]. Finally, our findings were supported
by the recent report of a naturally occurring mutation at
MCT8 position 445 (R445C, reviewed in [4]).
To further evaluate the reliability of our MCT8 model,
we retrospectively examined other recently published
functional data. An alanine scanning study focussing on
all 10 cysteines within hMCT8 [16] was performed to
test the contribution to homo-oligomeric MCT8
arrangements. The alanine mutants did not alter
MCT8–mediated substrate transport. We have mapped
these cysteines on our MCT8 model and found that
none of the cysteine side chains participates directly in
the substrate channel, except C283 close to the cytosolic
entry side (figure 5). Accordingly, the cysteine to alanine
substitutions (shorter side chains than of cysteines) did
not alter properties of the transport channel and are
likely not involved in transport. Finally, seven (C184,
C231, C244, C281, C283, C491, C497) out of the ten
cysteines are located inside the transmembrane part.
Therefore, only the extracellular 3 cysteines (C436,
C481, C546) in a non-reducing environment could in
principle participate in intermolecular dimer-contacts
via disulfide bridges. Of note, they are not in spatial dis-
tances to each other (more than 20 Å) to form intramo-
lecular disulfide bridges.
Naturally occurring side chain substitutions are indicators
for functionally and structurally important MCT regions
We here explored the spatial localization of MCT8
mutations in the three-dimensional “inside-open” MCT8
homology model. First of all, we found by comparison
of hMCT amino acid sequences and the MCT8 model
that:
1. All single side chain missense mutations are located
within TMHs or at helix-loop transitions (figure 2A),
but not at extra- or intracellular loops. This finding
highlights the transmembrane helices as most important
for MCT8 function.
2. Pathogenic MCT8 mutants are localized to a high
degree at conserved wild-type amino acids among
MCTs (figure 4).
Conserved residues of related proteins (like the MCT
family) indicate amino acids of functional and/or struc-
tural importance. Wild-type positions of MCT8 muta-
tions at helices 5 to 12 are conserved more than 50%
Figure 3 Homology model of the human MCT8 with mapped details of pathogenic mutations and potential localization of the
transport channel switching region. A) The top-view on the MCT8 homology model with annotated pathogenic side chain substitutions
reveals a detailed insight into the distribution of known mutations. The colour code given to the side chains (sticks) is in accordance with
described colour scheme in figure 1. B) This clipped surface top-view visualizes the spatial relation between the wild-type amino acids of mutant
positions and the “inside-open” transport channel conformation. Amino acids that are localized at the transition between the open and closed
channel part are coloured red (red circle). These residues might be involved in the switching process between the “inside-open” and “outside-
open” conformations.
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Figure 4 Alignment of the human MCTs with highlighted positions of pathogenic mutations reported for MCT8. This alignment
compares the human MCT sequences and in addition MCT8 of rat and mice (MCT8 are red boxed). Conserved residues are marked by different
colours according to their biophysical properties (blue - positively charged, red - negatively charged, green/orange - hydrophobic, gray -
hydrophilic, black – proline, cyan - aromatic). Black boxed are the potential dimensions of the transmembrane helices (TMHs) based on the X-ray
structure of the E.coli Glycerol-3-phosphate transporter, another member of the major facilitator superfamily which was used as a structural
template to build the MCT8 homology model. Red stars above the hMCT8 sequence indicating positions where naturally occurring mutations for
the hMCT8 are reported. Few of them are at positions with a high degree of conservation like R445 (R8.50). In addition, the positively charged
residues and histidines hypothesized in this study as to be potentially involved in substrate transport (figure 7) are annotated above the
sequences in blue. For each helix the most highly conserved residue is numbered according to a unifying numbering system (see Material and
Methods).
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among hMCTs. Three out of nineteen positions are
conserved to 100%, four positions are conserved to 90%.
In conclusion, it can be speculated that mutations at
highly conserved amino acids likely cause pathogenic
dysfunction. These positions appear as essential for
hMCTs and structural/functional similarities especially
at these particular positions are preserved.
Furthermore, we have subdivided pathogenic muta-
tions into two main groups (figure 1): I. mutations
either at or to proline/glycine which leads likely to
structural changes between helices or directly at helices
(prolines in helices supporting kinks); II. side chain sub-
stitutions located close to the putative substrate channel
which might directly modify substrate transport.
Figure 5 Distribution of cysteines in the human MCT8 homology model. To evaluate our MCT8 model on consistency we examined
already published functional data. Alanine mutants of all ten cysteines in the hMCT8 did not alter MCT8 functions such as substrate transport
[16]. A) With the exception of C283 at the cytosolic channel region our “inside-open” MCT8 model suggests that none of the MCT8 cysteine side
chains directly participates in the substrate channel. In conclusion the experimental data and the implications from the MCT8 model are in
agreement with each other. B) The cytosolic view with clipped intracellular loops shows that most of the cysteines are localized at distance from
the substrate channel. (Cavities in the model are highlighted by inner surfaces.)
Figure 6 Details of the T3 receptor beta complex in comparison with determinants of the MCT8 transport channel. A) The crystal
structure of the T3 receptor beta ligand binding domain (PDB code 3GWS [20] backbone-ribbon) reveals detailed insights into the binding
mode of this hormone. Surrounded by hydrophobic (green) and aromatic (cyan) amino acids, T3 (magenta) binding is characterized by H-bonds
to an arginine and a histidine. According to the assumption of analogy for T3 binding (T3 receptor, A) to different proteins, such specific
complementary residues might be generally mandatory for hormone binding/transport. B) In the MCT8 homology model two histidines (H192,
H415) and three positively charged residues (R445, K418, R301) are predicted to point inside the putative substrate transport channel (sticks with
labels). Further amino acids in the transport channel are also highlighted by sticks: orange – hydrophilic residues without charges, magenta –
negatively charged residues.
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Mutations at or to prolines and glycines, respectively,
cause structural misfolding
Interestingly, for MCT8 the majority (7 out of 9) of pro-
line/glycine mutations (P/G-X, e.g. P537L) or mutants
to proline (X-P, e.g. L512P) are located at helices 9-12
(figure 1, figure 3A). They involve conserved amino
acids among the MCTs. Prolines and glycines are
known to support kinks and bulges in helices [17-19].
This has strong impact on both the helix (local) and the
protein (global) structure. For that reason structural
alterations of the helices by mutations at or to proline/
glycine, respectively, can be assumed to cause MCT8
misfolding by modification of helix conformation. In
consequence deficiencies in cell surface expression of
such mutants have been observed [10]. Additionally, for
the P/G-X mutants it can be assumed that substitutions
of prolines or glycines with enlarged side chains like leu-
cine are predestined to cause sterical clashes in a tight
micro-environment of interacting side chains.
Pathogenic MCT8 mutations indicate important
determinants and regions for substrate transport
Wild-type amino acids of those mutants that are close
to the transport channel (figures 2A and 3B) might be
directly or indirectly involved in substrate transport
mechanisms. Interestingly, amino acids H192, S194,
G221, A224, and R445 are located at a similar spatial
layer which lies at the closed bottom substrate channel
viewed from the intracellular side (figures 3B and 5B).
These residues are in a specific region that must be
modified or “opened” for substrate transport. Therefore,
they might be involved in the switching mechanism
between an “inside-open” and “outside-open” conforma-
tion. Particular residues here may function thereby as
gate keepers as already described for R445 [7]. Interac-
tions between neighbouring helices as suggested for
R445 may constrain the “bottle neck like” conformation
of this region. During the conformational switching
such constraints must be re-arranged to enable struc-
tural movements of the helices. However, it needs more
experimental characterization to clarify the detailed
molecular involvement of each of these wild-type amino
acids, but we can assume that the pathogenic substitu-
tions do not maintain MCT8 transport function.
Potential T3 binding sites in the MCT8 substrate
transport channel
One may assume that MCT8 substrates bind along the
open channel-part in the “inside-open” MCT8 model. In
order to identify amino acids which may contribute to
substrate binding and transport, we used a comparative
strategy. The previously published crystal structure of
the T3-bound thyroid hormone receptor (TR) beta
ligand binding domain (PDB code 3GWS [20]) reveals
detailed insights in T3 binding (figure 6A). Surrounded
by hydrophobic aliphatic and aromatic amino acids, T3
is bound by H-bonds to an arginine and a histidine (fig-
ure 6A). Side chains of these two residues are in a
Figure 7 Applications for potential modes of T3 binding at MCT8 by comparison between the crystallized hormone/receptor complex
and the structural MCT8 model. A) T3 is bound to its receptor in a specific mode characterized by several molecular interactions like H-bonds
to a positively charged arginine and a histidine (figure 6A). The amino acid side chains are in a certain distance to each other in a range
between 14.4 and 15.3 Å. B) Measurement of the distances between the histidines and positively charges residues in the MCT8 model (“inside-
open” conformation) reveals three combinations of Arg-His pairings in a similar distance to each other (red translucent regions V1-V3 (V–variant)).
Although the distance between R445 (highly conserved among the MCTs) and H192 is around 15 Å, some hydrophilic amino acids are in close
spatial distance (V1) which would cause sterical clashes with the T3 substrate. In another transporter conformation this might be different. Of
note, R445 and H192 are functionally important as demonstrated by pathogenic mutations (figure 3A). The importance of R445 for transport was
also shown by directed mutagenesis.
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defined spatial distance to each other of around 14-15 Å
(figure 7A). Assuming a certain degree of analogy in T3
binding, such specific residues, their biochemical prop-
erties and their arrangement in the binding pocket,
might represent a typical pattern for T3 binding. In the
MCT8 homology model two histidines (H1921.67,
H4157.53) and three positively charged residues
(R4458.50, K4188.56, R3015.39) are predicted to point
towards the substrate transport channel (figure 6B).
Measurement of the side chain distances between the
histidines and positively charged residues (“inside-open”
MCT8 conformation, figure 7B) reveals three combina-
tions of Arg-His pairs at a similar distance to each other
as in the T3-TR beta complex. These pairs and dis-
tances are shown in figure 7B as potential binding
regions for T3 in the channel cavity. Of note, although
the distance between R445 (highly conserved among the
MCTs) and H192 is around 15 Å like in the T3 recep-
tor, few other amino acids are in close spatial proximity
likely would lead to sterical clashes with substrate in
this conformation. In an “outside-open” conformation
this might be different.
Nevertheless, R445 and H192 have already been
shown to be functionally important (references in [7]).
The present comparative analysis suggests two new
potential key-players for substrate transport: R3015.39
(highly conserved among the hMCTs 1-13) and
H4157.53 (conserved in hMCT8, hMCT10, hMCT11,
and hMCT13). Both amino acids have not yet been
investigated experimentally. R301 at TMH5 is, in con-
trast to the two other positively charged residues inside
the channel, localized more closely to the intracellular
side. Noticeably, in all three potential variants of T3
binding modes always one amino acid is linked to the
potential “switching sensitive” region at the closed bottle
neck of the transport channel.
Conclusions
Naturally occurring mutations in MCT8 provide mole-
cular insights into protein regions important for protein
folding and the switching mechanism during substrate
transport. This was shown here by the assignment of
mutations especially at TMH9 to TMH12 leading to
MCT8 misfolding. Furthermore, by highlighting specific
positions of pathogenic mutations in the three-dimen-
sional structure, we have specified a critical region for
the transition between the postulated “inside-open” and
“outside-open” conformations. These amino acids are
located at a bottle neck of the transport channel cavity,
surrounded by substrate binding-sensitive amino acids.
Our MCT8 model has guided several new insights in
the relationship between sequence, structure and func-
tion of this transporter. This model is in accordance
with experimental data and is predictive to support the
identification of functional key-player amino acids.
Future studies based on this model are aimed to clarify
unknown details of molecular events at MCT8 and
likely at other members of the MCT family. This
includes: 1. identification of the complete set of trans-
port-sensitive residues, 2. description of structural re-
arrangements, 3. identification of binding-sensitive resi-
dues, 4. details of ligand binding with molecular expla-
nation of substrate specificity. Finally, for comprehensive
understanding the relevance of oligomeric MCT8 con-
stellations must be considered.
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